calcium channel blockers ( verapamil , diltiazem and lidocaine ) , a calmodulin antagonist ( chlorpromazine ) , adrenergic receptor blockers ( yohimbine , tolazoline and propranolol ) , and a cardiac glycoside ( digoxin ) were evaluated for their effects on monensin toxicity following their 30 min pretreatments in mice ip .
C0007158
cardiac glycoside
C0012265
digoxin